Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Ropinirole CR - High Dose Group
Total, all-cause mortality	Ropinirole CR - Maintenance Group
Total, all-cause mortality	Ropinirole CR - High Dose Group: Long Term Phase
Total, all-cause mortality	Ropinirole CR - Maintenance Group: Long Term Phase
Total, other adverse events	Ropinirole CR - High Dose Group	13	61
Total, other adverse events	Ropinirole CR - Maintenance Group	11	20
Total, other adverse events	Ropinirole CR - High Dose Group: Long Term Phase	14	44
Total, other adverse events	Ropinirole CR - Maintenance Group: Long Term Phase	13	18
Total, serious adverse events	Ropinirole CR - High Dose Group	2	61
Total, serious adverse events	Ropinirole CR - Maintenance Group	4	20
Total, serious adverse events	Ropinirole CR - High Dose Group: Long Term Phase	0	44
Total, serious adverse events	Ropinirole CR - Maintenance Group: Long Term Phase	1	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01929317/event-totals